Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
April 1, 2024ESMO OpenOpen Access

A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations

View Full Paper
Ask AI
Bookmark
Share

Authors

JRJordi RodónEREstelamari RodríguezMMMichael L. Maitland

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rodón et al. (2024) studied this question.

synapsesocial.com/papers/68e70d8cb6db643587686fddhttps://doi.org/10.1016/j.esmoop.2024.102961
View Full Paper
Ask AI
Bookmark
Share